Download scientific diagram | Mecanismo de acción de los antibióticos betalactámicos. Tomado de: (Suárez & Gudiol, ). from publication: Determinación. Antibióticos betalactamicos. Dr. Jairo Cerrato Toxicologo clinico. Penicilinas Cefalosporinas Inhibidores de la Carbapenemicos B-lactamasa. ANTIBIOTICOS BETALACTAMICOS. OC. Osvaldo Cabrera. Updated 13 March Transcript. RESISTENCIA. USOS CLINICOS. AMOXICILINA. DE PRIMERA .

Author: Tygokasa Voodoorisar
Country: South Africa
Language: English (Spanish)
Genre: Sex
Published (Last): 9 April 2014
Pages: 319
PDF File Size: 7.42 Mb
ePub File Size: 6.45 Mb
ISBN: 400-9-33744-174-7
Downloads: 21523
Price: Free* [*Free Regsitration Required]
Uploader: Daijora


Beta-lactam antibiotics have been traditionally considered first-line therapy. Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia. Scand J Infect Dis.

Study report GFXB Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults. We combined the evidence using meta-analysis and generated a summary of findings table following the GRADE approach. Kinasewitz G, Wood RG. Int J Antimicrob Agents.

Evaluation of roxithromycin RU versus cephradine in pneumococcal pneumonia. Medwave se preocupa por su privacidad y la seguridad de sus datos personales. Are new antibiotics better than beta-lactams for non-critical inpatients with community-acquired pneumonia? Empirical atypical coverage for inpatients with community-acquired pneumonia: Treatment of community-acquired pneumonia with moxifloxacin: Vogel F, Lode H.


Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin. Study report We concluded new antibiotics are not better than beta-lactam antibiotics for the treatment of non-critical inpatients with community-acquired pneumonia in relation to clinical failure or adverse effects.

Epub Sep Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia. Clinical phase III comparative study of intravenous levofloxacin and ceftriaxone in community-acquired pneumonia treatment.

Trovafloxacin versus high-dose amoxicillin 1 g three times daily in the treatment of community-acquired bacterial pneumonia.

A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia. Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified six systematic reviews including 36 randomized trials addressing this question.

There was a problem providing the content you requested

Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Safety and efficacy of sequential i. Cochrane Database Syst Rev. El resumen de los resultados es el siguiente:.


Sobre los desenlaces incluidos en este resumen. Infect Dis Clin Practice. Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: Chuard C, Regamey C. Efficacy and safety of temafloxacin versus those of amoxicillin in hospitalized beatlactamicos with community-acquired pneumonia.

Information reported in a systematic review. Clinical Microbiology and Infection.

Planta farmaceutica para antibioticos betalactamicos by Alejandra Ovalle on Prezi

New antibiotics could be more effective but the evidence is not clear until now, and its use could entail greater costs, an increase in bacterial resistance and other adverse effects. Sparfloxacin European Study Group. Su principal desarrollo es la base de datos Epistemonikos www. Chinese Journal of Antibiotics. Observation of the therapeutic effects of gatifloxacin on community acquired pneumonia.

Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia.